Literature DB >> 25089639

Fluorogen-peptide conjugates with tunable aggregation-induced emission characteristics for bioprobe design.

Ruoyu Zhang1, Youyong Yuan, Jing Liang, Ryan T K Kwok, Qing Zhu, Guangxue Feng, Junlong Geng, Ben Zhong Tang, Bin Liu.   

Abstract

Fluorogens with aggregation-induced emission (AIE) characteristics are attracting intense research interest, and an AIE-peptide conjugate strategy has been reported for developing turn-on probes based on hydrophilic peptide ligands. To build a model also suitable for hydrophobic ligands, we propose to fine-tune the AIE characteristics for probe design. In this work, an iconic AIE fluorogen tetraphenylethene (TPE) was designed to conjugate with peptide fragments containing different numbers of aspartic acid (D) units. Relationships between the numbers of D and the hydrophilicity, optical properties, and aggregate sizes and the AIE characteristics of TPE-peptide conjugates were investigated carefully. Five carboxyl groups were found to be the threshold to "turn off" the fluorescence of TPE. As a proof-of-concept, TPE-SS-D5 containing a cleavable disulfide bond was synthesized for thiol turn-on detection. The validated tunable AIE characteristic offers new opportunities to design fluorescence turn-on probes based on hydrophobic recognition elements and AIE fluorogens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25089639     DOI: 10.1021/am5036048

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  Fluorescent supramolecular hydrogels self-assembled from tetraphenylethene (TPE)/single amino acid conjugates.

Authors:  Nien-Tzu Chu; Rajan Deepan Chakravarthy; Nai-Chia Shih; Yen-Hsu Lin; Yen-Chu Liu; Jhong-Hua Lin; Hsin-Chieh Lin
Journal:  RSC Adv       Date:  2018-06-08       Impact factor: 4.036

Review 2.  Peptide-drug conjugates as effective prodrug strategies for targeted delivery.

Authors:  Yin Wang; Andrew G Cheetham; Garren Angacian; Hao Su; Lisi Xie; Honggang Cui
Journal:  Adv Drug Deliv Rev       Date:  2016-06-29       Impact factor: 15.470

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.